Home » Topics » BioWorld Science

BioWorld Science
RSS

Aptorum reports further interim phase I data on ALS-4

July 13, 2021

Identification of antivirulence compound ANT-3273 for P. aeruginosa infection

July 13, 2021

Dosing begins in phase I study of CB-010 in B-cell NHL

July 13, 2021

First patient treated in phase I study of INKmune in high-risk MDS

July 13, 2021

Hummingbird and MD Anderson collaborate to advance VISTA antagonist antibody, HMBD-002

July 13, 2021

EscharEx debridement agent demonstrates efficiency, safety in chronic wound study

July 13, 2021

ALG2-CDG model in zebrafish displays human phenotypes and hypo-N-glycosylation

July 13, 2021

Condensate drugs block RSV replication in vivo

July 13, 2021

Janssen Pharmaceutical discovers compounds for hepatitis B

July 13, 2021

New furaneol glycoside compounds divulged by Fudan University

July 13, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...